(Q79970742)
Statements
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea (English)
James Q Del Rosso
Guy F Webster
Mark Jackson
Marta Rendon
Phoebe Rich
Helen Torok